These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17644040)

  • 21. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 22. Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.
    Hostler CJ; Chen LF
    Expert Opin Pharmacother; 2013 Aug; 14(11):1529-36. PubMed ID: 23683070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile: recent epidemiologic findings and advances in therapy.
    McMaster-Baxter NL; Musher DM
    Pharmacotherapy; 2007 Jul; 27(7):1029-39. PubMed ID: 17594209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
    Hardesty JS; Juang P
    Pharmacotherapy; 2011 Sep; 31(9):877-86. PubMed ID: 21923589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing C. difficile-associated diarrhea.
    Bailey EM
    Am J Health Syst Pharm; 1998 Jul; 55(13):1365. PubMed ID: 9659963
    [No Abstract]   [Full Text] [Related]  

  • 28. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance.
    Shah D; Dang MD; Hasbun R; Koo HL; Jiang ZD; DuPont HL; Garey KW
    Expert Rev Anti Infect Ther; 2010 May; 8(5):555-64. PubMed ID: 20455684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Clostridium difficile infection.
    Gerding DN; Muto CA; Owens RC
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S32-42. PubMed ID: 18177219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S; Nisii C; Petrosillo N
    Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
    Garey KW; Jiang ZD; Bellard A; Dupont HL
    J Clin Gastroenterol; 2009 Jan; 43(1):91-3. PubMed ID: 18385603
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Banawas SS
    Biomed Res Int; 2018; 2018():8414257. PubMed ID: 29682562
    [No Abstract]   [Full Text] [Related]  

  • 34. Fidaxomicin: a new option for the treatment of Clostridium difficile infection.
    Johnson AP; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2788-92. PubMed ID: 22865382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
    Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diarrhea associated with Clostridium difficile: one-year experience in a general hospital].
    Bouza E; Padilla B; Catalán P; Sánchez-Carrillo C; Blázquez R; Peláez T
    Rev Clin Esp; 1996 Jul; 196(7):424-30. PubMed ID: 8804202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
    Oldfield EC
    Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
    Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
    Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile infection: clinical challenges and management strategies.
    Walters PR; Zuckerbraun BS
    Crit Care Nurse; 2014 Aug; 34(4):24-34; quiz 35. PubMed ID: 25086091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.